The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Advances in the diagnosis, pathogenesis and treatment of CIDP
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991) · Neurology · doi:10.1212/wnl.41.5.617 · Cited by 856
Chronic Inflammatory Polyradiculoneuropathy
Millichap, J. G. (1997) · Pediatric Neurology Briefs · doi:10.15844/pedneurbriefs-11-12-6 · Cited by 822
Hughes, R. A., Donofrio, P., Bril, V., Dalakas, M. C., Deng, C., Hanna, K., Hartung, H.-P., Latov, N., Merkies, I. S., & van Doorn, P. A. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70329-0 · Cited by 674
Self-citationHughes, R., Bensa, S., Willison, H., Van Den Bergh, P., Comi, G., Illa, I., Nobile‐Orazio, E., Van Doorn, P., Dalakas, M., Bojar, M., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1088 · Cited by 628
Self-citationChronic Inflammatory Demyelinating Polyneuropathy
Köller, H., Kieseier, B. C., Jander, S., & Hartung, H.-P. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041347 · Cited by 511
Multifocal demyelinating neuropathy with persistent conduction block
Lewis, R. A., Sumner, A. J., Brown, M. J., & Asbury, A. K. (1982) · Neurology · doi:10.1212/wnl.32.9.958 · Cited by 502
Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Dyck, P. J., Daube, J., O'Brien, P., Pineda, A., Low, P. A., Windebank, A. J., & Swanson, C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140801 · Cited by 489
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
Dyck, P. J., O'Brien, P. C., Oviatt, K. F., Dinapoli, R. P., Daube, J. R., Bartleson, J. D., Mokri, B., Swift, T., Low, P. A., & Windebank, A. J. (1982) · Annals of Neurology · doi:10.1002/ana.410110205 · Cited by 483
Dyck, P. J., Litchy, W. J., Kratz, K. M., Suarez, G. A., Low, P. A., Pineda, A. A., Windebank, A. J., Karnes, J. L., & O'Brien, P. C. (1994) · Annals of Neurology · doi:10.1002/ana.410360607 · Cited by 471
Clinical Immunology: Principles and Practice
Rich, R. R. (2012) · Cited by 410
Hahn, A. F., Bolton, C. F., Pillay, N., Chalk, C., Benstead, T. J., Bril, V., Shumak, K. H., Vandervoort, M. K., & Feasby, T. E. (1996) · Brain · doi:10.1093/brain/119.4.1055 · Cited by 409
Chronic relapsing polyneuritis
Prineas, J. W., & McLeod, J. G. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90213-6 · Cited by 368
Incidence and prevalence of CIDP and the association of diabetes mellitus
Laughlin, R. S., Dyck, P. J., Melton, L. J., Leibson, C., Ransom, J., & Dyck, P. J. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181aaea47 · Cited by 314
Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment
Dalakas, M. C., & Engel, W. K. (1981) · Annals of Neurology · doi:10.1002/ana.410090719 · Cited by 277
Self-citationChronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England
Lunn, M. P. T., Manji, H., Choudhary, P. P., Hughes, R. A. C., & Thomas, P. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.5.677 · Cited by 276
Doorn, P. A. V., Brand, A., Strengers, P. F. W., Meulstee, J., & Vermeulen, M. (1990) · Neurology · doi:10.1212/wnl.40.2.209 · Cited by 274
Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy
Van Den Bergh, P. Y. K., & Piéret, F. (2004) · Muscle & Nerve · doi:10.1002/mus.20022 · Cited by 251
Chronic Inflammatory Polyradiculoneuropathy
Dyck, P. J., Lais, A. C., Ohta, M., Bastron, J. A., Okazaki, H., & Groover, R. V. (1975) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)09732-0 · Cited by 244
Tackenberg, B., Jelčić, I., Baerenwaldt, A., Oertel, W. H., Sommer, N., Nimmerjahn, F., & Lünemann, J. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807319106 · Cited by 242
Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod Mice
Salomon, B., Rhee, L., Bour-Jordan, H., Hsin, H., Montag, A., Soliven, B., Arcella, J., Girvin, A. M., Miller, S. D., & Bluestone, J. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.677 · Cited by 229
Combined azathioprine and prednisone in chronic inflammatory‐demyelinating polyneuropathy
Dyck, P. J., O'Brien, P., Swanson, C., Low, P., & Daube, J. (1985) · Neurology · doi:10.1212/wnl.35.8.1173 · Cited by 227
Vermeulen, M., van Doorn, P. A., Brand, A., Strengers, P. F., Jennekens, F. G., & Busch, H. F. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.1.36 · Cited by 223
van Schaik, I. N., Eftimov, F., van Doorn, P. A., Brusse, E., van den Berg, L. H., van der Pol, W. L., Faber, C. G., van Oostrom, J. C., Vogels, O. J., Hadden, R. D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70021-1 · Cited by 219
Ting, K. M. (2016) · Encyclopedia of Machine Learning and Data Mining · doi:10.1007/978-1-4899-7502-7_758-1 · Cited by 207
Chronic immune sensory polyradiculopathy: A possibly treatable sensory ataxia
Sinnreich, M., Klein, C. J., Daube, J. R., Engelstad, J., Spinner, R. J., & Dyck, P. J. B. (2004) · Neurology · doi:10.1212/01.wnl.0000142507.12763.58 · Cited by 207
B cells as therapeutic targets in autoimmune neurological disorders
Dalakas, M. C. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0901 · Cited by 202
Self-citationDemyelinating Neuropathy in Diabetes Mellitus
Sharma, K. R. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.758 · Cited by 202
Immunoglobulin and Complement Deposits in Nerves of Patients With Chronic Relapsing Polyneuropathy
Dalakas, M. C., & Engel, W. K. (1980) · Archives of Neurology · doi:10.1001/archneur.1980.00500590061010 · Cited by 175
Self-citationP0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy
Yan, W. X., Archelos, J. J., Hartung, H., & Pollard, J. D. (2001) · Annals of Neurology · doi:10.1002/ana.1129 · Cited by 162
Hartung, H., Reiners, K., Schmidt, B. G., Stoll, G., & Toyka, K. V. (1991) · Annals of Neurology · doi:10.1002/ana.410300110 · Cited by 162
Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy
Hughes, R. A., Allen, D. C., Makowska, A. M., & Gregson, N. A. (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2006.00061.x · Cited by 160
Kieseier, B. C., Tani, M., Mahad, D., Oka, N., Ho, T. W., Woodroofe, M. N., Griffin, J. W., Toyka, K. V., Ransohoff, R. M., & Hartung, H. (2002) · Brain · doi:10.1093/brain/awf070 · Cited by 159
Ilyas, A. A., Mithen, F. A., Dalakas, M. C., Chen, Z.-W., & Cook, S. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90217-9 · Cited by 155
Self-citationGorson, K. C., van Schaik, I. N., Merkies, I. S. J., Lewis, R. A., Barohn, R. J., Koski, C. L., Cornblath, D. R., Hughes, R. A., Hahn, A. F., Baumgarten, M., et al. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00284.x · Cited by 154
Distinguishing acute-onset CIDP from Guillain–Barré syndrome with treatment related fluctuations
Ruts, L., van Koningsveld, R., & van Doorn, P. A. (2005) · Neurology · doi:10.1212/01.wnl.0000167549.09664.b8 · Cited by 151
Chronic polyneuropathies in Vest‐Agder, Norway
Mygland, Å., & Monstad, P. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00187.x · Cited by 148
Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy
Chiò, A., Cocito, D., Bottacchi, E., Buffa, C., Leone, M. A., Plano, F., Mutani, R., Calvo, A., & PARCIDP, T. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.114868 · Cited by 147
Yan, W. X., Taylor, J. M., Andrias‐Kauba, S., & Pollard, J. D. (2000) · Annals of Neurology · Cited by 145
Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy
Good, J. L., Chehrenama, M., Mayer, R. F., & Koski, C. L. (1998) · Neurology · doi:10.1212/wnl.51.6.1735 · Cited by 142
Lonigro, A., & Devaux, J. J. (2008) · Brain · doi:10.1093/brain/awn281 · Cited by 138
Mahdi‐Rogers, M., Swan, A. V., van Doorn, P. A., & Hughes, R. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003280.pub3 · Cited by 132
Invited Article: Inhibition of B cell functions
Dalakas, M. C. (2008) · Neurology · doi:10.1212/01.wnl.0000313840.27060.bf · Cited by 119
Self-citationChildhood chronic inflammatory demyelinating neuropathies: Clinical course and long-term follow-up
Nevo, Y., Pestronk, A., Kornberg, A. J., Connolly, A. M., Yee, W.-C., Iqbal, I., & Shield, L. K. (1996) · Neurology · doi:10.1212/wnl.47.1.98 · Cited by 112
Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome
Ryan, M. M., Grattan‐Smith, P. J., Procopis, P. G., Morgan, G., & Ouvrier, R. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00119-x · Cited by 105
An open label clinical trial of complement inhibition in multifocal motor neuropathy
Fitzpatrick, A., Mann, C., Barry, S., Brennan, K., Overell, J. R., & Willison, H. J. (2011) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2011.00328.x · Cited by 104
Jun, L., Xu, W., Zhang, Z. W., Huang, H., Zhang, L. M., & Zhou, J. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00294.x · Cited by 100
Lee, D., Linker, R. A., Paulus, W., Schneider‐Gold, C., Chan, A., & Gold, R. (2007) · Muscle & Nerve · doi:10.1002/mus.20909 · Cited by 100
Magda, P., Latov, N., Brannagan, T. H., Weimer, L. H., Chin, R. L., & Sander, H. W. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1755 · Cited by 100
Practical considerations on the use of rituximab in autoimmune neurological disorders
Kosmidis, M. L., & Dalakas, M. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609356135 · Cited by 95
Self-citationTreatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin
Cornblath, D. R., Chaudhry, V., & Griffin, J. W. (1991) · Annals of Neurology · doi:10.1002/ana.410300119 · Cited by 92
Vital, C. (2000) · Ultrastructural Pathology · doi:10.1080/019131200750060023 · Cited by 88
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With Pulsed Oral Steroids
Muley, S., Kelkar, P., & Parry, G. J. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1460 · Cited by 85
Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy
Marsh, E. A., Hirst, C. L., Llewelyn, J., Cossburn, M., Reilly, M. M., Krishnan, A., Doran, M., Ryan, A., Coles, A. J., Jones, J., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5437-3 · Cited by 83
Maimone, D., Annunziata, P., Simone, I. L., Livrea, P., & Guazzi, G. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90284-6 · Cited by 81
Dalakas, M. C., Teräväinen, H., & Engel, W. K. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050180033012 · Cited by 79
Self-citationOdaka, M., Yuki, N., & Hirata, K. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1096-y · Cited by 75
Chi, L., Wang, H., & Wang, W. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00158.x · Cited by 73
Gladstone, D. E., Prestrud, A. A., & Brannagan, T. H. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.10104.x · Cited by 73
Dalakas, M. C. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2005.12.008 · Cited by 72
Self-citationChronic inflammatory demyelinating polyneuropathy associated with malignant melanoma
Bird, S. J., Brown, M. J., Shy, M. E., & Scherer, S. S. (1996) · Neurology · doi:10.1212/wnl.46.3.822 · Cited by 69
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy
Hughes, R. A. C., Swan, A. V., & van Doorn, P. A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003280 · Cited by 68
Nodes of Ranvier and Paranodes in Chronic Acquired Neuropathies
Cifuentes-Díaz, C., Dubourg, O., Irinopoulou, T., Vigny, M., Lachkar, S., Decker, L., Charnay, P., Denisenko, N., Maisonobe, T., Léger, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014533 · Cited by 66
Health-related quality-of-life improvements in CIDP with immune globulin IV 10%
Merkies, I. S. J., Bril, V., Dalakas, M. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a0fd80 · Cited by 64
Self-citationCIDP – the relevance of recent advances in Schwann cell/axonal neurobiology
Pollard, J. D., & Armati, P. J. (2011) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2011.00323.x · Cited by 63
Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies
Kiefer, R. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.362 · Cited by 58
Sanvito, L., Makowska, A. M., Gregson, N. A., Nemni, R., & Hughes, R. A. (2009) · Autoimmunity · doi:10.1080/08916930903140907 · Cited by 58
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Intravenous Immunoglobulin
Hahn, A. F. (1998) · Neurology · doi:10.1212/wnl.51.6_suppl_5.s16 · Cited by 52
Iijima, M., Tomita, M., Morozumi, S., Kawagashira, Y., Nakamura, T., Koike, H., Katsuno, M., Hattori, N., Tanaka, F., Yamamoto, M. P., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd1139 · Cited by 51
Gene expression profiling in chronic inflammatory demyelinating polyneuropathy
Renaud, S., Hays, A. P., Brannagan, T. H., Sander, H. W., Edgar, M. A., Weimer, L. H., Olarte, M. R., Dalakas, M. C., Xiang, Z., Danon, M. J., et al. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.021 · Cited by 46
Self-citationExpression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies
Hu, W. W., Janke, A., Ortler, S., Hartung, H., Leder, C., Kieseier, B. C., & Wiendl, H. (2007) · Neurology · doi:10.1212/01.wnl.0000250240.99311.9d · Cited by 35
Anti-SGPG antibody in CIDP: Nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy
Tagawa, Y., Yuki, N., & Hirata, K. (2000) · Muscle & Nerve · Cited by 33
Notturno, F., Pace, M., Angelis, M. V. D., Caporale, C. M., Giovannini, A., & Uncini, A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.003 · Cited by 33
Oka, N., Akiguchi, I., Nagao, M., Nishio, T., Kawasaki, T., & Kimura, J. (1994) · Neurology · doi:10.1212/wnl.44.5.946 · Cited by 25
Druker, B. J., Rosenthal, D. S., & Canellos, G. P. (1989) · Cancer · doi:10.1002/1097-0142(19890315)63:6<1166::aid-cncr2820630621>3.0.co;2-5 · Cited by 18
Autoimmune peripheral neuropathies
Dalakas, M. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04404-2.10066-1 · Cited by 8
Self-citationTaniguchi, J., Sawai, S., Mori, M., Kubo, T., Kanai, K., Misawa, S., Isose, S., Yamashita, T., & Kuwabara, S. (2009) · Annals of Neurology · doi:10.1002/ana.21784 · Cited by 7
Cited by
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Morgan, R. A., Chinnasamy, N., Abate-Daga, D., Gros, A., Robbins, P. F., Zheng, Z., Dudley, M. E., Feldman, S. A., Yang, J. C., Sherry, R. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182829903 · Cited by 1,148
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
Mathey, E. K., Park, S. B., Hughes, R. A. C., Pollard, J. D., Armati, P. J., Barnett, M. H., Taylor, B. V., Dyck, P. J. B., Kiernan, M. C., & Lin, C. S.-Y. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309697 · Cited by 440
Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
Lünemann, J. D., Nimmerjahn, F., & Dalakas, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.253 · Cited by 301
Self-citationSialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Quast, I., Keller, C. W., Maurer, M. A., Giddens, J. P., Tackenberg, B., Wang, L.-X., Münz, C., Nimmerjahn, F., Dalakas, M. C., & Lünemann, J. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82695 · Cited by 269
Self-citationSialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury
Zhang, G., Massaad, C. A., Gao, T., Pillai, L., Bogdanova, N., Ghauri, S., & Sheikh, K. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.020 · Cited by 38
“…but a large body of work favors synergism of cellular and humoral immune elements in the pathogenesis of these inflammatory neuropathic disorders (Dalakas, 2011; Hughes and Cornblath, 2005; Hughes et al., 1999; Ilyas et al., 1988; Quarles et al., 1990; Willison and Yuki, 2002; Yuki BS,…”
Background
Metadata
- Authors
- Dalakas, M. C.
- Venue
- Nature Reviews Neurology
- Published
- 2011-08-16
- Volume
- 7
- Issue
- 9
- Pages
- 507-517
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2078712131
- Cited by
- 296
- References
- 79
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.